{
    "Trade/Device Name(s)": [
        "Dade\u00ae Thrombin Reagent",
        "Dade\u00ae Owren's Veronal Buffer",
        "Fibrinogen Determination System"
    ],
    "Submitter Information": "Dade Behring Marburg GmbH",
    "510(k) Number": "K050928",
    "Predicate Device Reference 510(k) Number(s)": [
        "BK860038"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KQJ"
    ],
    "Summary Letter Date": "June 29, 2005",
    "Summary Letter Received Date": "April 14, 2005",
    "Submission Date": "April 13, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7340"
    ],
    "Regulation Name(s)": [
        "System, Fibrinogen Determination"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Clotting time measurement (Clauss assay principle)"
    ],
    "Methodologies": [
        "Quantitative assay for fibrinogen determination"
    ],
    "Submission Type(s)": [
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Dade\u00ae Thrombin Reagent for quantitative fibrinogen determination in plasma using clotting time assay",
    "Indications for Use Summary": "For use in the quantitative determination of fibrinogen in plasma and to accelerate coagulation of anticoagulated samples for immunohematology studies",
    "fda_folder": "Hematology"
}